Cardiol Therapeutics (CRDL) Stock Highlights

1.28 | -2.29%

2024-12-21 06:30:00

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The companys lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Statistics

Range Today

1.28 1.44

Volume Today 406.1K

Range 1 Year

0.79 3.12

Volume 1 Year 103.19M

Range 3 Year

0.45 3.12

Volume 3 Year 207.69M

Range 10 Year

0.45 10

Volume 10 Year 306.5M

Highlights

Market Capitalization 165.46M (small)

Floating Shares 66.64M

Current Price 1.28

Price To Earnings -6.87

Price To Book 8.96

Earnings Per Share -0.3

Payout Ratio 0%

Performance

Latest -2.29%

1 Month -20.99%

3 Months -42.34%

6 Months -36.32%

1 Year +48.84%

3 Years -36%

5 Years -58.75%

10 Years -65.79%

Benchmarks

Market Capitalization

0 / 54

Gross Profits

0 / 39

Total Revenue

0 / 50

Total Rank

0 / 54

Free Cashflow

0 / 54

Performance 5 years

0 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.